Compare MIRA & ROMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MIRA | ROMA |
|---|---|---|
| Founded | 2020 | 2018 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.7M | 144.7M |
| IPO Year | 2023 | 2024 |
| Metric | MIRA | ROMA |
|---|---|---|
| Price | $1.52 | $2.01 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 253.9K | 6.4K |
| Earning Date | 11-13-2025 | 12-26-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,640,101.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 59.60 |
| 52 Week Low | $0.73 | $0.58 |
| 52 Week High | $2.45 | $4.66 |
| Indicator | MIRA | ROMA |
|---|---|---|
| Relative Strength Index (RSI) | 50.15 | 34.46 |
| Support Level | $1.52 | $1.52 |
| Resistance Level | $1.69 | $2.59 |
| Average True Range (ATR) | 0.08 | 0.32 |
| MACD | 0.00 | -0.04 |
| Stochastic Oscillator | 31.10 | 43.97 |
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.
Roma Green Finance Ltd is principally engaged in the provision of ESG, corporate governance and risk management as well as sustainability and climate change-related advisory services. The company works closely with its clients to help them understand, identify, manage, and overcome various business matters arising from such factors related to ESG, sustainability and climate change. Geographically, the company generates its revenue from Hong Kong and Singapore.